What does PHARMACIES SERVAIS do?

PHARMACIES SERVAIS is a pharmacy in Wavre. Private Limited, started on 10 August 1994, 21 establishments.

What is the address of PHARMACIES SERVAIS?

The registered office of PHARMACIES SERVAIS is located at Chaussée de Namur 5, 1300 Wavre.

Is PHARMACIES SERVAIS still active?

Yes. According to the CBE (29 October 2026) PHARMACIES SERVAIS is active, legal situation “Normale toestand”, started on 10 August 1994.

Is PHARMACIES SERVAIS registered on Peppol?

Yes, PHARMACIES SERVAIS is registered on the Peppol network with ID 0208:0453242495.

What is the enterprise number of PHARMACIES SERVAIS?

The enterprise number of PHARMACIES SERVAIS is BE0453242495.

When was PHARMACIES SERVAIS founded?

PHARMACIES SERVAIS was founded on 10 August 1994.

Who are the directors of PHARMACIES SERVAIS?

According to the 2025 annual accounts, the directors of PHARMACIES SERVAIS are: Pharmateam Invest SRL.

Is PHARMACIES SERVAIS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 August 1994; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 21 establishments in the CBE.

How much profit did PHARMACIES SERVAIS make in 2025?

PHARMACIES SERVAIS posted a profit after taxes of € 1,493,386 in financial year 2025.

What is the revenue of PHARMACIES SERVAIS?

In its most recent annual accounts (2025), PHARMACIES SERVAIS reported revenue of € 52,161,738.

How much does an employee at PHARMACIES SERVAIS earn?

The average wage cost per full-time employee at PHARMACIES SERVAIS was € 67,300 in 2025: staff costs of € 9.4 million for 139.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIES SERVAIS have?

According to the 2025 annual accounts, PHARMACIES SERVAIS has 139.7 full-time equivalents (FTE).

PHARMACIES SERVAIS (Private Limited) - Wavre

Dossier PHARMACIES SERVAIS, printed on 29 October 2026 from databakkes.be/en/0453242495/pharmacies-servais. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 35 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIES SERVAIS from Wavre, company number BE0453242495, closed financial year 2025 with a result of € 1.5 million after tax. For that financial year PHARMACIES SERVAIS recorded revenue of € 52.2 million and equity of € 7.9 million. Compared with financial year 2024, the result moved from € 407,412 to € 1.5 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Growing

€ 7.9 million

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1.5 million

▲ 267% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.1 million

▲ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 7.1 million.

People and assets in 2025

Full-time equivalents

139.7

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 5.4 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 9.4 million

▲ 2% vs 2024

€ 67,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 299,259

▼ 22% vs 2024

Of which on lease € 60,760.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 11.4 million

▼ 11% vs 2024

€ 1.8 million is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 4.7 million

▲ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 44 days on average.

Taxes and wages

€ 2.2 million

▲ 6% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 43,480,940 Revenue 2022: € 43,480,940 First fiscal year in the series	€ 45,650,781 Revenue 2023: € 45,650,781 ▲ 5% vs 2022 (€ 43,480,940) Favourable step	€ 48,862,131 Revenue 2024: € 48,862,131 ▲ 7% vs 2023 (€ 45,650,781) Favourable step	€ 52,161,738 Revenue 2025: € 52,161,738 ▲ 7% vs 2024 (€ 48,862,131) Favourable step	▲ 7%
Profit after taxes	€ 711,994 Profit after taxes 2022: € 711,994 First fiscal year in the series	€ -6,963 Profit after taxes 2023: € -6,963 ▼ € 718,957 vs 2022 (€ 711,994) Unfavourable step	€ 407,412 Profit after taxes 2024: € 407,412 ▲ € 414,375 vs 2023 (€ -6,963) Favourable step	€ 1,493,386 Profit after taxes 2025: € 1,493,386 ▲ 267% vs 2024 (€ 407,412) Favourable step	▲ 267%
Equity	€ 6,186,625 Equity 2022: € 6,186,625 First fiscal year in the series	€ 6,175,525 Equity 2023: € 6,175,525 Unchanged (€ 6,186,625) Unfavourable step	€ 6,403,801 Equity 2024: € 6,403,801 ▲ 4% vs 2023 (€ 6,175,525) Favourable step	€ 7,893,050 Equity 2025: € 7,893,050 ▲ 23% vs 2024 (€ 6,403,801) Favourable step	▲ 23%
Total debts	€ 22,058,768 Total debts 2022: € 22,058,768 First fiscal year in the series	€ 24,151,940 Total debts 2023: € 24,151,940 ▲ 9% vs 2022 (€ 22,058,768) Unfavourable step	€ 21,244,590 Total debts 2024: € 21,244,590 ▼ 12% vs 2023 (€ 24,151,940) Favourable step	€ 20,732,599 Total debts 2025: € 20,732,599 ▼ 2% vs 2024 (€ 21,244,590) Favourable step	▼ 2%
Cash	€ 1,304,732 Cash 2022: € 1,304,732 First fiscal year in the series	€ 966,997 Cash 2023: € 966,997 ▼ 26% vs 2022 (€ 1,304,732) Unfavourable step	€ 944,939 Cash 2024: € 944,939 ▼ 2% vs 2023 (€ 966,997) Unfavourable step	€ 1,061,352 Cash 2025: € 1,061,352 ▲ 12% vs 2024 (€ 944,939) Favourable step	▲ 12%
Land & buildings	€ 8,396,061 Land & buildings 2022: € 8,396,061 First fiscal year in the series	€ 10,144,616 Land & buildings 2023: € 10,144,616 ▲ 21% vs 2022 (€ 8,396,061) Unchanged	€ 9,192,815 Land & buildings 2024: € 9,192,815 ▼ 9% vs 2023 (€ 10,144,616) Unchanged	€ 8,825,730 Land & buildings 2025: € 8,825,730 ▼ 4% vs 2024 (€ 9,192,815) Unchanged	▼ 4%
Retained profit	€ 5,323,126 Retained profit 2022: € 5,323,126 First fiscal year in the series	€ 5,421,654 Retained profit 2023: € 5,421,654 ▲ 2% vs 2022 (€ 5,323,126) Favourable step	€ 5,654,066 Retained profit 2024: € 5,654,066 ▲ 4% vs 2023 (€ 5,421,654) Favourable step	€ 7,147,452 Retained profit 2025: € 7,147,452 ▲ 26% vs 2024 (€ 5,654,066) Favourable step	▲ 26%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 50,000) Unchanged	€ 175,000 Dividend 2024: € 175,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 175,000) Unchanged	▼ 100%
Bank debt	€ 13,653,139 Bank debt 2022: € 13,653,139 First fiscal year in the series	€ 16,390,286 Bank debt 2023: € 16,390,286 ▲ 20% vs 2022 (€ 13,653,139) Unfavourable step	€ 12,764,173 Bank debt 2024: € 12,764,173 ▼ 22% vs 2023 (€ 16,390,286) Favourable step	€ 11,418,135 Bank debt 2025: € 11,418,135 ▼ 11% vs 2024 (€ 12,764,173) Favourable step	▼ 11%
Balance sheet total	€ 28,268,544 Balance sheet total 2022: € 28,268,544 First fiscal year in the series	€ 30,349,504 Balance sheet total 2023: € 30,349,504 ▲ 7% vs 2022 (€ 28,268,544) Unchanged	€ 27,669,317 Balance sheet total 2024: € 27,669,317 ▼ 9% vs 2023 (€ 30,349,504) Unchanged	€ 28,645,463 Balance sheet total 2025: € 28,645,463 ▲ 4% vs 2024 (€ 27,669,317) Unchanged	▲ 4%
Employees (FTE)	134.4 Employees (FTE) 2022: 134.4 First fiscal year in the series	140.8 Employees (FTE) 2023: 140.8 ▲ 6.4 vs 2022 (134.4) Unchanged	139.8 Employees (FTE) 2024: 139.8 ▼ 1 vs 2023 (140.8) Unchanged	139.7 Employees (FTE) 2025: 139.7 ▼ 0.1 vs 2024 (139.8) Unchanged	▼ 0.1

Key figures of PHARMACIES SERVAIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIES SERVAIS?

What happened at PHARMACIES SERVAIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New establishment in Wavre. KBO
Jun 11, 2026 New annual accounts for financial year 2025: profit of € 1.5 million (▲ 267% vs 2024). Source: NBB ↗
May 1, 2026 New establishment in Wavre. KBO
Apr 1, 2022 New establishment in Genappe. KBO
Jan 1, 2020 New establishment in Chaumont-Gistoux. KBO
Jan 1, 2019 New establishment in Lasne. KBO
May 22, 2017 New establishment in Hoeilaart. KBO
Sep 22, 2016 New establishment in Ukkel. KBO

In short

From € 711,994 profit in 2022 to € 1.5 million profit in 2025.

Paid € 1.6 million in corporate taxes since 2022.

Best year ever: 2025, with € 1.5 million profit.

Paid out € 225,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Pharmateam Invest SRL

PHARMACIES SERVAIS

Sogipharma 100%

Apotheek de Linde 100%

Prince d'Orange 100%

Pharmacie D'Ohain 100%

Behind PHARMACIES SERVAIS is Pharmateam Invest SRL. It owns 100% of Sogipharma, 100% of Apotheek de Linde, 100% of Prince d'Orange, 100% of Pharmacie D'Ohain and 100% of Pharmacentre itself.

Directors

According to the 2025 annual accounts

Pharmateam Invest SRL

Director · represented by Emmanuelle Servais

Also active at: SOGIPHARMA, PHARMACIE DU PRINCE D'ORANGE

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Namur 5

1300 Wavre

2.068.668.817

Chaussée d'Alsemberg 577

1420 Braine-l'Alleud

Active since 17 October 1994

2.256.820.410

Waterloosesteenweg 1142-1144

1180 Ukkel

Active since 22 September 2016

2.149.198.712

Boulevard de la Cense 39

1410 Waterloo

Active since 4 October 2005

2.189.041.659

Chaussée de Wavre 154

1390 Grez-Doiceau

Active since 1 April 2010

2.219.945.562

Chaussée de Bruxelles 183

1410 Waterloo

Active since 1 April 2013

2.219.945.760

Rue du Noly, St-Denis 23 box A

5081 La Bruyère

Active since 1 January 2013

2.219.945.859

Chaussée de Louvain 420

1380 Lasne

Active since 1 April 2013

2.219.946.057

Chaussée de Jodoigne 2 box C

1315 Incourt

Active since 1 January 2013

2.219.946.354

Grand'Route 61 box A

1435 Mont-Saint-Guibert

Active since 1 April 2013

2.223.815.367

Chaussée de Wavre(Jod.) 90 box A

1370 Jodoigne

Active since 18 November 2013

2.223.815.466

Avenue Belle Vue 2

1410 Waterloo

Active since 18 November 2013

2.229.759.784

Chaussée de Nivelles 86

1420 Braine-l'Alleud

Active since 4 March 2014

2.248.153.261

Rue des Ecoles 3

1341 Ottignies-Louvain-la-Neuve

Active since 15 December 2015

2.265.228.231

Waversesteenweg 182

1560 Hoeilaart

Active since 22 May 2017

2.284.921.310

Route de Genval 9

1380 Lasne

Active since 1 January 2019

2.003.148.978

Chaussée de Wavre 415

1390 Grez-Doiceau

Active since 20 October 1994

2.298.073.718

Chaussée de Huy 19

1325 Chaumont-Gistoux

Active since 1 January 2020

2.330.816.166

Rue Dernier Patard 130

1470 Genappe

Active since 1 April 2022

2.388.231.456

Rue du Chemin de Fer 25

1300 Wavre

Active since 1 May 2026

2.390.354.073

Rue des Combattants 92

1301 Wavre

Active since 1 July 2026

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

PHARMACENTRE same network

€ 75,069 gross margin · 2025

SOGIPHARMA same network

€ 114,207 gross margin · 2025

Pharmacie d’Ohain same network

€ 50,690 gross margin · 2025

PHARMATEAM INVEST same network

€ 630,000 revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0453.242.495

VAT number

BE 0453.242.495

Registered office

Chaussée de Namur 5, 1300 Wavre

Names & denominations

PHARMACIES SERVAIS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

10 August 1994

Peppol

Active · Active since 26 Mar 2025

Contact

[email protected] 0475 372 803

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIES SERVAIS

Warning lights

Financials

What happened to PHARMACIES SERVAIS?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions